Daniala Weir

Daniala Weir

PhD (McGill University)
MSc (University of Alberta)
BSc (University of Alberta)

T. 416-946-5410
daniala.weir@utoronto.ca

Twitter: @danialaw
LinkedIn
ResearchGate
Google Scholar

Faculty Supervisor: Walter Wodchis

Research Interests

I am an epidemiologist with a focus on drug utilization and health services research in complex patients with multiple chronic conditions.

I completed my MSc in Epidemiology in the School of Public Health, University of Alberta under the supervision of Dr. Dean Eurich within the Alliance for Canadian Health Outcomes Research in Diabetes (ACHORD). During my masters, I conducted research related to the comparative safety and effectiveness of antidiabetic agents in patients with diabetes and heart failure, evaluation of the common drug review in Canada, cardiovascular medication adherence in rural and urban settings, the role of multimorbidity in hospitalized patients with community acquired pneumonia and the impact of continuity of care in patients with type 2 diabetes.

I recently completed my PhD in Epidemiology in the Department of Epidemiology, Biostatistics and Occupational Health, McGill University under the supervision of Dr. Robyn Tamblyn within the McGill Clinical and Health Informatics Research Group. During this time, I contributed to research related to population level utilization of benzodiazepines in Alberta, the utilization and accuracy of Quebec’s Electronic Health Record, the impact of electronically enabled medication reconciliation on post-discharge adverse health outcomes in hospitalized patients, developing and piloting a patient centred application to enhance medication management following hospital discharge, and the burden and cost associated with cost-related medication non-adherence in Canada. My doctoral dissertation was focused around preventable sources of medication related morbidity and mortality at transitions in care for hospitalized patients. More specially, I evaluated the incidence and impact of failure to follow hospital medication changes in the post-discharge period as well as evaluated the prevalence of and risk associated with potentially inappropriate medications prescribed at hospital discharge.

I will focus on two areas of research during my CIHR funded post-doctoral training under the supervision of Dr. Walter Wodchis. The first will be related to optimizing medication prescribing for those living with multiple chronic conditions using machine learning. The second project will focus on improving the quality of care transitions between hospital and home for complex patients.